The role of airborne proteins in atopic dermatitis
- PMID: 20725535
- PMCID: PMC2921737
The role of airborne proteins in atopic dermatitis
Abstract
Atopic dermatitis is a common, chronic skin condition. A subpopulation of patients may have cutaneous exposure to common airborne proteins exacerbating their disease through direct proteolytic activity, direct activation of proteinase-activated receptor-2 itch receptors, and immunoglobulin E binding. The most common airborne proteins significant in atopic dermatitis include house dust mites, cockroach, pet dander, and multiple pollens. The literature on atopy patch testing, skin-prick testing, and specific IgE is mixed, with greater support for the use of atopy patch test. Patients with airborne proteins contributing to their disease typically have lesions predominately on air-exposed skin surfaces including the face, neck, and arms; a history of exacerbations after exposure to airborne proteins; severe disease resistant to conventional therapies; and concurrent asthma. Treatment strategies include airborne protein avoidance, removal of airborne proteins from the skin, and barrier repair. Further research is needed to establish the benefit of allergen-specific immunotherapy.
Figures
References
-
- Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002;46:361–370. - PubMed
-
- Mancini AJ, Kaulback K, Camlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol. 2008;25(1):1–6. - PubMed
-
- Nakamura T, Hirasawa Y, Takai T, et al. Reduction of skin barrier function by proteolytic activity of a recombinant house dust mite major allergen der f 1. J Invest Dermatol. 2006;126(12):2719–2723. - PubMed
-
- Jeong SK, Kim HJ, Youm JK, et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol. 2008;128(8):1930–1939. - PubMed
-
- Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol. 2006;118(6):1292–1298. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials